Published in Public Health Rep on July 17, 1996
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol (1998) 7.01
Mycotoxins. Clin Microbiol Rev (2003) 5.59
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol (1998) 5.13
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc (2008) 3.46
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol (1999) 2.15
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety. Br J Clin Pharmacol (2003) 1.82
Uptake of Aspergillus fumigatus Conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. Infect Immun (2002) 1.67
Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol Biol Cell (2003) 1.41
Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus. J Clin Microbiol (1998) 1.36
Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J Bacteriol (1999) 1.34
Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition. Antimicrob Agents Chemother (2000) 1.24
Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev (2004) 1.22
Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol (1999) 1.15
Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev (1998) 1.12
Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal. PLoS Pathog (2014) 1.07
Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrob Agents Chemother (2000) 1.05
Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun (2000) 1.01
Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages. Clin Exp Immunol (1998) 0.98
Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob Agents Chemother (2003) 0.98
Fungi and the rise of mammals. PLoS Pathog (2012) 0.94
Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med (2003) 0.91
Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts. Antimicrob Agents Chemother (2013) 0.90
Free-living protozoa in two unchlorinated drinking water supplies, identified by phylogenic analysis of 18S rRNA gene sequences. Appl Environ Microbiol (2009) 0.90
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands. Ann Hematol (2010) 0.80
Cell-type-specific transcriptional profiles of the dimorphic pathogen Penicillium marneffei reflect distinct reproductive, morphological, and environmental demands. G3 (Bethesda) (2013) 0.80
Host defence to pulmonary mycosis. Can J Infect Dis (1999) 0.80
Detection of Candida albicans by mass spectrometric fingerprinting. Curr Microbiol (2011) 0.79
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Virulence (2015) 0.79
Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Clin Exp Immunol (2000) 0.78
Elucidation of substrate specificity in Aspergillus nidulans UDP-galactose-4-epimerase. PLoS One (2013) 0.77
First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front Microbiol (2016) 0.75
Synthesis and Antimicrobial Activities of His(2-aryl)-Arg and Trp-His(2-aryl) Classes of Dipeptidomimetics. Medchemcomm (2014) 0.75
Ethyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and Biofilms. PLoS One (2016) 0.75
Fungi fighting back. Environ Health Perspect (1997) 0.75
Identification and Sequencing of Candida krusei Aconitate Hydratase Gene Using Rapid Amplification of cDNA Ends Method and Phylogenetic Analysis. Jundishapur J Microbiol (2015) 0.75
Subsurface pressure profiling: a novel mathematical paradigm for computing colony pressures on substrate during fungal infections. Sci Rep (2015) 0.75
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
Resistance of Candida species to fluconazole. Antimicrob Agents Chemother (1995) 9.04
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis (1993) 8.63
Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci (1980) 7.31
Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med (1988) 6.78
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis (1991) 6.43
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature (1988) 5.21
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol (1994) 4.27
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med (1990) 4.25
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol (1985) 3.97
Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) (1990) 3.95
Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med (1991) 3.69
Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev (1994) 3.58
Molecular mechanisms of drug resistance in fungi. Trends Microbiol (1994) 3.55
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Human mycoses: drugs and targets for emerging pathogens. Science (1994) 2.52
Epidemiology of vaginitis. Am J Obstet Gynecol (1991) 2.46
Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis (1994) 2.41
Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis (1993) 2.17
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun (1991) 2.11
Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol (1994) 2.07
Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med (1993) 1.83
Coccidioidomycosis. West J Med (1993) 1.79
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Human infections due to Malassezia spp. Clin Microbiol Rev (1992) 1.61
The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) (1988) 1.56
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS (1994) 1.55
The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis (1991) 1.47
Candida species: emerging hospital bloodstream pathogens. Infect Control Hosp Epidemiol (1991) 1.42
Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clin Infect Dis (1992) 1.34
Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clin Infect Dis (1995) 1.30
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) (1990) 1.19
Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group. J Heart Lung Transplant (1994) 1.14
A multistate outbreak of sporotrichosis associated with sphagnum moss. Am J Epidemiol (1992) 1.11
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1994) 1.07
Drug resistance in human pathogenic fungi. Eur J Epidemiol (1992) 1.06
Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: an outbreak in a military reserve unit. J Infect Dis (1995) 1.05
High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant (1993) 1.05
Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05
Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol (1993) 1.04
Mycotic vulvovaginitis: a broad overview. Am J Obstet Gynecol (1991) 0.95
An outbreak of histoplasmosis in a prison. Am J Epidemiol (1985) 0.93
Coccidioidomycosis and heart transplantation. J Heart Lung Transplant (1993) 0.90
Emergence of unusual opportunistic pathogens in AIDS: a review. Clin Infect Dis (1992) 0.88
Sporotrichosis in the acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.86
Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) (1984) 0.86
Acute pulmonary histoplasmosis outbreak following home renovation. Md Med J (1988) 0.82
Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS (1991) 0.82
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. Clin Transpl (1994) 0.79
[The pulmonary form of Schaumann-Boeck's disease]. Rev Clin Esp (1956) 0.79
Bone-marrow transplantation and related infections. Semin Respir Infect (1993) 0.79
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
Boron nitride nanotubes. Science (1995) 5.53
Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med (1995) 4.11
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96
Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88
An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. N Engl J Med (1998) 3.45
Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks. J Clin Microbiol (1984) 3.33
Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26
Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science (1986) 3.16
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
Emerging foodborne diseases. Emerg Infect Dis (1997) 3.05
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73
Cloned, random chromosomal sequences as probes to identify Salmonella species. J Infect Dis (1986) 2.58
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
Prediction of new low compressibility solids. Science (1989) 2.46
Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42
Career interruptions and hours practiced: comparison between young men and women physicians. Can J Public Health (1990) 2.37
Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist (2000) 2.29
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak. Antimicrob Agents Chemother (1982) 2.27
Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA (1988) 2.26
Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome. Science (1981) 2.25
Distribution and three-dimensional structure of intercellular junctions in canine myocardium. Circ Res (1989) 2.25
On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther (1974) 1.97
Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983. Science (1984) 1.85
Evaluation of isolated cases of salmonellosis by plasmid profile analysis: introduction and transmission of a bacterial clone by precooked roast beef. J Infect Dis (1983) 1.81
Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun (1990) 1.80
Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79
Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology (1973) 1.74
Epidemic salmonellosis from cheddar cheese: surveillance and prevention. Am J Epidemiol (1980) 1.72
Decreased vascular relaxation in hypertension. J Pharmacol Exp Ther (1976) 1.72
Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis. Lancet (1983) 1.70
A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. JAMA (1984) 1.70
Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med (1979) 1.66
Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology (1997) 1.64
An assessment of patient-related economic costs in an outbreak of salmonellosis. N Engl J Med (1978) 1.63
Usefulness of plasmid profiles for differentiation of Shigella isolates in Bangladesh. J Clin Microbiol (1984) 1.61
Shigellosis in day care centers: use of plasmid analysis to assess control measures. Pediatr Infect Dis (1983) 1.61
Turtle-associated salmonellosis in the United States. Effect of Public Health Action, 1970 to 1976. JAMA (1980) 1.56
The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study. Circulation (1984) 1.55
A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA (1997) 1.54
Spinal anaesthesia induced by intrathecal magnesium sulphate. Anaesthesia (1996) 1.54
Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol (1993) 1.54
Outbreak of pseudoinfection with Tsukamurella paurometabolum traced to laboratory contamination: efficacy of joint epidemiological and laboratory investigation. Clin Infect Dis (1992) 1.53
Brain abscess due to Gordona terrae in an immunocompromised child: case report and review of infections caused by G. terrae. Clin Infect Dis (1994) 1.53
Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science (1988) 1.51
Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping). J Clin Microbiol (1992) 1.49
Rapid group A streptococcal antigen detection kit: effect on antimicrobial therapy for acute pharyngitis. Pediatrics (1988) 1.49
Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol (1991) 1.49
Spinal anaesthesia with midazolam in the rat. Can J Anaesth (1997) 1.49
The design and conduct of clinical trials to limit missing data. Stat Med (2012) 1.48
Intracranial Wegener's granulomatosis. Neurology (1993) 1.47
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis (1999) 1.47
Central venous catheter sepsis caused by unusual Gordona (Rhodococcus species: identification with a digoxigenin-labeled rDNA probe. Clin Infect Dis (1992) 1.44
Self-esteem in children medically managed for attention deficit disorder. Pediatrics (1989) 1.43
Rhodococcus equi cavitary pneumonia in HIV-infected patients: an unsuspected opportunistic pathogen. J Acquir Immune Defic Syndr (1992) 1.43
M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther (2000) 1.40
Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int J Syst Evol Microbiol (2000) 1.39
Identification and epidemiological typing of clinical and environmental isolates of the genus Rhodococcus with use of a digoxigenin-labeled rDNA gene probe. Clin Infect Dis (1992) 1.39
Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther (1981) 1.37
Sporadic community-acquired Legionnaires' disease in the United States. A case-control study. Ann Intern Med (1979) 1.37
Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-, and 32-kilodalton antigens of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.36
Measurement of the thermal properties of human skin. A review. J Invest Dermatol (1977) 1.34
Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA (1987) 1.34
Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34
Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J Clin Microbiol (1983) 1.34
Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis. Infection (1997) 1.32
Sterile, caseous mitral anular abscess. J Am Coll Cardiol (1983) 1.32
Editorials: Updating sphygmomanometry. Am J Cardiol (1974) 1.31
Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun (1985) 1.30
Hantavirus pulmonary syndrome: an emerging infectious disease. Science (1993) 1.28
Water-related disease outbreaks in the United States, 1981. J Infect Dis (1983) 1.27
Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol (1987) 1.25
Chylothorax: diagnosis by lipoprotein electrophoresis of serum and pleural fluid. Thorax (1977) 1.24
The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. J Infect Dis (1994) 1.22
Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol (1992) 1.22
Nosocomial Pseudomonas pickettii colonization associated with a contaminated respiratory therapy solution in a special care nursery. J Clin Microbiol (1985) 1.21
Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med (1985) 1.21
The changing epidemiology of adult botulism in the United States. Am J Epidemiol (1986) 1.21
Factors associated with Pseudomonas pickettii intrinsic contamination of commercial respiratory therapy solutions marketed as sterile. Appl Environ Microbiol (1985) 1.20
Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella. J Infect Dis (1984) 1.19
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci (2000) 1.19
Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories. J Clin Microbiol (1997) 1.19
Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA (2000) 1.18
Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J (1994) 1.18
Measles vaccine: do we need new vaccines or new programs? Science (1994) 1.18
Nocardia farcinica sternotomy site infections in patients following open heart surgery. J Infect Dis (1998) 1.17
Cardiac mortality in Alaska's indigenous and non-Native residents. Int J Epidemiol (1993) 1.16
Nocardia, nocardiosis and mycetoma. Med Mycol (1998) 1.15
In vitro relaxation of arteries and veins by prazosin: alpha-adrenergic blockade with no direct vasodilation. Blood Vessels (1979) 1.15
Unusual responses to electrocutaneous stimulation in refractory cervicobrachial pain: clues to a neuropathic pathogenesis. Clin Exp Rheumatol (1993) 1.15
Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle. J Pharmacol Exp Ther (1985) 1.13
Fatal nosocomial Legionnaires' disease: clinical and epidemiologic characteristics. Ann Intern Med (1979) 1.13
Referred pain of peripheral nerve origin: an alternative to the "myofascial pain" construct. Clin J Pain (1994) 1.13
Catheter-related bacteremia caused by Oerskovia turbata. J Clin Microbiol (1989) 1.12
Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg (1984) 1.12